Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Clinical trial NCT07220642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07220642
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2027-05-11
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.